[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.

Need advice? Keen to get the best deal? Call now on +44 (0)1494 771734

>

Lixiana (Atrial Fibrillation) - Analysis and Forecasts to 2022

Lixiana (Atrial Fibrillation) - Analysis and Forecasts to 2022

Table of Contents

Market Briefing
Published: May 2012
Pages: 38
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1250.00  Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Indication Areas

Table of Contents

1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Atrial Fibrillation Market 4
2.2 Epidemiology 4
2.3 Etiology and Risk Factors 5
2.3.1 Symptoms associated with AF 6
2.4 GlobalData Analysis and Forecasts Report Guidance 7
3 Atrial Fibrillation: Market Characterization 8
3.1 Atrial Fibrillation Market 8
3.2 Atrial Fibrillation Market Forecasts and CAGR 9
3.3 Drivers of Atrial Fibrillation Market 9
3.3.1 High Unmet need 9
3.3.2 Strong Pipeline 10
3.3.3 Increase in prevalence and ageing populations 10
3.3.4 Organisation of Awareness Campaigns 11
3.4 Barriers in Atrial Fibrillation Market 12
3.4.1 Limitations in established therapies 12
3.4.2 High cost of emerging therapies 12
4 Classification in Atrial Fibrillation: Introduction 13
4.1 AF Classification 13
4.1.1 Pathophysiology of AF 14
4.1.2 Diagnosis in Atrial Fibrillation 15
4.1.3 Impact of Atrial Fibrillation 16
5 Treatment Options and Management in Atrial Fibrillation 17
5.1 Rate control and Rhythm control 17
5.2 Rate Control Versus Rhythm Control 19
6 Lixiana 20
6.1 Introduction 20
6.2 Mechanism of Action 20
6.3 Clinical Studies 20
6.4 Approval History of Lixiana 21
6.5 Factors Affecting Sales of Lixiana 21
6.5.1 First in class in Japan 21
6.5.2 Successful results from phase III clinical trials 21
6.5.3 Convenient dosing with no monitoring 21
6.6 Drug Evaluation 22
6.6.1 Drug Risk Benefit Score 22
6.6.2 Intensity of Competition 23
6.7 Sales Forecast 23
6.7.1 Target Patient Pool of Lixiana 23
6.7.2 Dosing 24
6.7.3 Market Penetration 24
6.7.4 Annual Cost of Therapy 25
6.7.5 Sales Projections of Lixiana 26
7 Appendix 35
7.1 Market Definitions 35
7.2 Abbreviations 35
7.3 Research Methodology 35
7.3.1 Coverage 35
7.3.2 Secondary Research 36
7.3.3 Forecasting 36
7.3.4 Number of Patients Approved to Take the Drug 36
7.3.5 Net Penetration of Drug 37
7.3.6 Net Annual Dosing 37
7.3.7 Annual Cost of Therapy 37
7.4 Drug Sales Estimates Model 37
7.5 Contact Us 37
7.6 Disclaimer 38
7.7 Sources 38

For full details, please email deborahf@cmsinfo.com

Top of Page